Jiayu Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Jiayu Yu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aiguo Meng
Department of Laboratory Medicine, Affiliated hospital of North China university of science and technology, Tangshan, China
1 shared publication - Hui Sun
State Key Laboratory of High-Efficiency Coal Utilization and Green Chemical Engineering, School of Chemistry and Chemical Engineering, Ningxia University, Yinchuan 750021, China
1 shared publication - Huijuan Shi
Department of Dermatovenereology , The General Hospital of Ningxia Medical University , Yinchuan , China , nxmu.edu.cn
1 shared publication - Jiawei Si
Department of Clinical Medicine, Ningxia Medical University, Ningxia, China
1 shared publication - Jing Zhang
Affiliated Hospital of North China University of Science and Technology, Tangshan, China; Key Laboratory of Medical Molecular Testing and Diagnosis in Tangshan, Tangshan, China
1 shared publication - Lijun Zhu
Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, 310030, Zhejiang, China.
1 shared publication
Latest Publications
- 27 September 2022
- Published by Elsevier in Neuroscience
- Vol. 504, 10-20
Micro Ribonucleic Acid 27a Aggravates Ferroptosis During Early Ischemic Stroke of Rats Through Nuclear Factor Erythroid-2-Related Factor 2
- 27 September 2022
- Published by Elsevier in Neuroscience
- Vol. 504, 10-20
Micro Ribonucleic Acid 27a Aggravates Ferroptosis During Early Ischemic Stroke of Rats Through Nuclear Factor Erythroid-2-Related Factor 2
- Open Access
- 26 March 2021
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 49 (3)
Association between serum visfatin levels and psoriasis and their correlation with disease severity: a meta-analysis
To determine the association between serum visfatin levels and psoriasis and to evaluate the correlation between serum visfatin levels and the severity of psoriasis. The electronic databases PubMed®, Embase® and the Cochrane Library were searched for articles published from inception to 1 May 2020. Data were extracted and then standard mean differences (SMDs) and 95% confidence intervals (CIs) were calculated for pooled estimates. A total of 11 studies met the inclusion criteria and were included (448 patients diagnosed with psoriasis and 377 controls). This meta-analysis demonstrated that patients with psoriasis had significantly higher levels of visfatin than the controls (SMD = 0.90, 95% CI 0.52, 1.28). Subgroup analyses showed that differences in serum visfatin levels between the patient group and the control group were associated with ethnicity, Psoriasis Area and Severity Index (PASI) and body mass index. Additionally, a meta-analysis of correlations showed that visfatin levels in patients with psoriasis were positively correlated with PASI (r = 0.51, 95% CI 0.14, 0.75). This meta-analysis showed that serum visfatin levels in patients with psoriasis were significantly higher than those in the controls and a positive correlation between serum visfatin levels and psoriasis severity was observed.
- 26 March 2021
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 49 (3)
Open AccessAssociation between serum visfatin levels and psoriasis and their correlation with disease severity: a meta-analysis
To determine the association between serum visfatin levels and psoriasis and to evaluate the correlation between serum visfatin levels and the severity of psoriasis. The electronic databases PubMed®, Embase® and the Cochrane Library were searched for articles published from inception to 1 May 2020. Data were extracted and then standard mean differences (SMDs) and 95% confidence intervals (CIs) were calculated for pooled estimates. A total of 11 studies met the inclusion criteria and were included (448 patients diagnosed with psoriasis and 377 controls). This meta-analysis demonstrated that patients with psoriasis had significantly higher levels of visfatin than the controls (SMD = 0.90, 95% CI 0.52, 1.28). Subgroup analyses showed that differences in serum visfatin levels between the patient group and the control group were associated with ethnicity, Psoriasis Area and Severity Index (PASI) and body mass index. Additionally, a meta-analysis of correlations showed that visfatin levels in patients with psoriasis were positively correlated with PASI (r = 0.51, 95% CI 0.14, 0.75). This meta-analysis showed that serum visfatin levels in patients with psoriasis were significantly higher than those in the controls and a positive correlation between serum visfatin levels and psoriasis severity was observed.